SYNH - Syneos Health Inc - Class A
Close
42.98
0.010 0.023%
Share volume: 0
Last Updated: Wed 27 Sep 2023 10:00:00 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$42.97
0.01
0.02%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | |
| Report Date | 2022-04-29 | 2022-08-02 | 2022-11-04 | 2023-02-16 | 2023-05-10 | 2023-08-09 | |
| Cash flow financing | -36.572 M | -97.947 M | -54.968 M | -149.670 M | 199.000 K | 25.949 M | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash flow | 70.887 M | 99.902 M | 132.375 M | 123.817 M | 30.424 M | -33.682 M | |
| Net income | 46.176 M | 77.744 M | 87.049 M | 55.528 M | -72.149 M | 793.000 K | |
| Depreciation | 62.202 M | 61.221 M | 61.514 M | 62.242 M | 61.587 M | 59.332 M | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 1.596 B | 1.607 B | 1.647 B | 1.645 B | 1.651 B | 1.700 B | |
| Investing Cashflow | -25.497 M | -25.566 M | -28.484 M | -26.087 M | -27.622 M | -18.905 M | |
| Net Borrowings | 2.688 B | 2.610 B | 2.512 B | 2.381 B | 2.376 B | 2.453 B | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | -23.474 M | -24.438 M | -21.921 M | -23.626 M | -27.509 M | -17.962 M | |
| Cash Change | 119.151 M | 105.988 M | 170.100 M | 112.004 M | 111.055 M | 82.276 M |